cas 521282-12-2|| where to buy 3-(azepane-1-sulfonyl)-4-chloro-N-(4H-1,2,4-triazol-3-yl)benzamide

Produktname:3-(azepane-1-sulfonyl)-4-chloro-N-(4H-1,2,4-triazol-3-yl)benzamide

IUPAC Name:3-(azepane-1-sulfonyl)-4-chloro-N-(4H-1,2,4-triazol-3-yl)benzamide

: CAS：521282-12-2; Molekulare Formel：C15H18ClN5O3S; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 521282-12-2 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:521282-12-2; Molekulare Formel:C15H18ClN5O3S; Schmelzpunkt:-; SMILES-Code:ClC1=C(C=C(C=C1)C(=O)NC1=NN=CN1)S(=O)(=O)N1CCCCCC1; Dichte:

: Katalognummer:CM859329; Molekulargewicht:383.85; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.